Pharmacy

Your Article Summary

See Latest Articles

Data from largest GOLD Stage II patient population treated with tiotropium highlight the benefits of earlier treatment of COPD
Boehringer Ingelheim, 08/31/09

A new analysis of the landmark UPLIFT trial, published today in the Lancet, shows that tiotropium administered to Chronic Obstructive Pulmonary Disease patients with moderate disease severity produced significant and sustained improvements in lung function for up to 4 years.1 This pre–specified subgroup analysis involved 2,739 patients – the largest group of early stage COPD patients treated with a long–acting anticholinergic in a randomised, placebo–controlled study.

Today in Drug Trials...keeping you current

Receive free subspecialty "5-minute updates" via email

A 25-week, open-label trial investigating rivastigmine transdermal patches with concomitant memantine in mild-to-moderate Alzheimers disease: a post hoc analysis
Current Medical Research and Opinion, 11/25/09

Bayesian Modelling of Healthcare Resource Use in Multinational Randomized Clinical Trials
PharmacoEconomics, 11/24/09

Pandemic 2009 Influenza Update: Pandemrix data in children and adolescents from 3 to 17 years of age
GlaxoSmithKline, 11/24/09

 See all of Drug Trials

Today in Other Drugs...keeping you current

Receive free subspecialty "5-minute updates" via email

Persistence with injectable antidiabetic agents in members with type 2 diabetes in a commercial managed care organization
Current Medical Research and Opinion, 11/25/09

Anti-relapse medications: Preclinical models for drug addiction treatment
Pharmacology & Therapeutics, 11/25/09

Glibenclamide-related excess in total and cardiovascular mortality risks: Data from large Ukrainian observational cohort study
Diabetes Research and Clinical Practice, 11/25/09

 See all of Other Drugs